Literature DB >> 14562059

Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion.

Marco Prinz1, Mathias Heikenwalder, Tobias Junt, Petra Schwarz, Markus Glatzel, Frank L Heppner, Yang-Xin Fu, Martin Lipp, Adriano Aguzzi.   

Abstract

Peripheral infection is the natural route of transmission in most prion diseases. Peripheral prion infection is followed by rapid prion replication in lymphoid organs, neuroinvasion and progressive neurological disease. Both immune cells and nerves are involved in pathogenesis, but the mechanisms of prion transfer from the immune to the nervous system are unknown. Here we show that ablation of the chemokine receptor CXCR5 juxtaposes follicular dendritic cells (FDCs) to major splenic nerves, and accelerates the transfer of intraperitoneally administered prions into the spinal cord. Neuroinvasion velocity correlated exclusively with the relative locations of FDCs and nerves: transfer of CXCR5-/- bone marrow to wild-type mice induced perineural FDCs and enhanced neuroinvasion, whereas reciprocal transfer to CXCR5-/- mice abolished them and restored normal efficiency of neuroinvasion. Suppression of lymphotoxin signalling depleted FDCs, abolished splenic infectivity, and suppressed acceleration of pathogenesis in CXCR5-/- mice. This suggests that prion neuroimmune transition occurs between FDCs and sympathetic nerves, and relative positioning of FDCs and nerves controls the efficiency of peripheral prion infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14562059     DOI: 10.1038/nature02072

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  71 in total

Review 1.  Emergence and natural selection of drug-resistant prions.

Authors:  James Shorter
Journal:  Mol Biosyst       Date:  2010-04-27

2.  Post-conversion sialylation of prions in lymphoid tissues.

Authors:  Saurabh Srivastava; Natallia Makarava; Elizaveta Katorcha; Regina Savtchenko; Reinhard Brossmer; Ilia V Baskakov
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

Review 3.  How do follicular dendritic cells interact intimately with B cells in the germinal centre?

Authors:  Chan-Sik Park; Yong Sung Choi
Journal:  Immunology       Date:  2005-01       Impact factor: 7.397

4.  Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations.

Authors:  Carole Crozet; Yea-Lih Lin; Clément Mettling; Chantal Mourton-Gilles; Pierre Corbeau; Sylvain Lehmann; Véronique Perrier
Journal:  J Cell Sci       Date:  2004-10-19       Impact factor: 5.285

Review 5.  Without nerves, immunology remains incomplete -in vivo veritas.

Authors:  Andrew J Shepherd; James E G Downing; Jaleel A Miyan
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

6.  Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies.

Authors:  Gaetano Donofrio; Frank L Heppner; Magdalini Polymenidou; Christine Musahl; Adriano Aguzzi
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 7.  Microglia in prion diseases.

Authors:  Adriano Aguzzi; Caihong Zhu
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

Review 8.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Bacterial colitis increases susceptibility to oral prion disease.

Authors:  Christina J Sigurdson; Mathias Heikenwalder; Giuseppe Manco; Manja Barthel; Petra Schwarz; Bärbel Stecher; Nike J Krautler; Wolf-Dietrich Hardt; Burkhardt Seifert; Andrew J S MacPherson; Irène Corthesy; Adriano Aguzzi
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

10.  Progress and problems in the biology, diagnostics, and therapeutics of prion diseases.

Authors:  Adriano Aguzzi; Mathias Heikenwalder; Gino Miele
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.